Precision radiation therapy requires managing motions of organs at risk that occur during treatment. While methods have been developed for real-time respiratory motion tracking, non-breathing intra-fractional variations (including gastric contractile motion) have seen little attention to date. The purpose of this study is to develop a cyclic gastric contractile motion prediction model to support real-time management during radiotherapy.. The observed short-term reproducibility of gastric contractile motion permitted development of a prediction model that (1) extracts gastric contraction motion phases from few minutes of golden angle stack of stars scanning (at patient positioning), (2) estimate gastric phase of real-time sampled data acquired during treatment delivery to these reconstructed phases and (3) predicting future gastric phase by linear extrapolation using estimation results from step 2 to account for processing and system latency times. Model was evaluated on three parameters including training time window for step 1, number of spokes for real-time sampling data in step 2 and future prediction time. Main. The model was tested on a population of 20 min data samples from 25 scans from 15 patients. The mean prediction error with 10 spokes and 2 min training was 0.3 ± 0.1 mm (0.1-0.7 mm) with 5.1 s future time, slowly rising to 0.6 ± 0.2 mm (0.2-1.1 mm) for 6.8 s future time and then increasing rapidly for longer forward predictions, for an average 3.6 ± 0.5 mm (2.8-4.7 mm) HD95 of gastric motion. Results showed that reducing of train time window (5-2 min) does not influence the prediction performance, while using 5 spokes increased prediction errors.. The proposed gastric motion prediction model has sufficiently accurate prediction performance to allow for sub-millimeter accuracy while allowing sufficient time for data processing and machine interaction and shows the potential for clinical implementation to support stomach motion tracking during radiotherapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324478 | PMC |
http://dx.doi.org/10.1088/1361-6560/ac9660 | DOI Listing |
Nutrients
December 2024
Food Chemistry and Nutraceutical Laboratory, Department of Pharmacy and Biotechnology (FaBiT), Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.
Background: Three herbal extracts ( Willd., Lorentz, and L.) were mixed with three essential oils ( Mill.
View Article and Find Full Text PDFPharmaceuticals (Basel)
December 2024
Laboratory of Gastrointestinal Physio-Pharmacology (LEFFAG), Federal University of Ceará, Coronel Nunes de Melo Street, 1315 Rodolfo Teófilo, Fortaleza 60416-030, CE, Brazil.
5-Fluorouracil (5-FU) is an antimetabolite widely prescribed in cancer treatments, but its use in highly proliferative tissues can cause significant problems such as mucositis. is a probiotic commonly used for protection against acute diarrhea, gastrointestinal dysbiosis and inflammatory bowel diseases. We investigated the effect of on 5-FU intestinal mucositis in mice.
View Article and Find Full Text PDFNeurogastroenterol Motil
January 2025
Division of Gastroenterology, University of Pisa, Pisa, Italy.
Introduction: High-resolution manometry (HRM) allows assessment of esophagogastric junction (EGJ) disruption. While type 3 EGJ predicts definitive gastroesophageal reflux disease (GERD), type 2 EGJ is less clearly implicated in GERD pathogenesis. This study aimed to characterize physiologic findings in type 2 EGJ to determine if the HRM-based Milan Score can define GERD within type 2 EGJ.
View Article and Find Full Text PDFBMC Complement Med Ther
December 2024
Department of Pediatrics, E-Da Hospital, I-Shou University, No. 1, Yi-Da Road, Yan-Chao District, Kaohsiung City, 82445, Taiwan, R.O.C..
Background: This study investigates multiple rapid swallows during high-resolution esophageal manometry (HREM) as an indicator of esophageal dysmotility following bariatric surgery. Gastrointestinal complications, including esophageal dysfunction, are common after bariatric surgery, and predictive markers are lacking.
Methods: Retrospective analysis of adult patients who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) between 2013 and 2023 and were subsequently evaluated by HREM.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!